Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.

× No keyword cloud information.

4 in total

Review 1. The future of proteasome inhibitors in relapsed/refractory multiple myeloma.

Authors: Robert Z Orlowski
Journal: Oncology (Williston Park) Date: 2011-11-15 Impact factor: 2.990

2. Targeting the insulin-like growth factor-1 receptor to overcome bortezomib resistance in preclinical models of multiple myeloma.

Authors: Deborah J Kuhn; Zuzana Berkova; Richard J Jones; Richard Woessner; Chad C Bjorklund; Wencai Ma; R Eric Davis; Pei Lin; Hua Wang; Timothy L Madden; Caimiao Wei; Veerabhadran Baladandayuthapani; Michael Wang; Sheeba K Thomas; Jatin J Shah; Donna M Weber; Robert Z Orlowski
Journal: Blood Date: 2012-08-29 Impact factor: 22.113

3. Endothelin-1 (ET-1) induces resistance to bortezomib in human multiple myeloma cells via a pathway involving the ETB receptor and upregulation of proteasomal activity.

Authors: Maria Vaiou; Evanthia Pangou; Panagiotis Liakos; Nikos Sakellaridis; George Vassilopoulos; Konstantinos Dimas; Christos Papandreou
Journal: J Cancer Res Clin Oncol Date: 2016-08-16 Impact factor: 4.553

4. Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study.

Authors: S K Kumar; J H Lee; J J Lahuerta; G Morgan; P G Richardson; J Crowley; J Haessler; J Feather; A Hoering; P Moreau; X LeLeu; C Hulin; S K Klein; P Sonneveld; D Siegel; J Bladé; H Goldschmidt; S Jagannath; J S Miguel; R Orlowski; A Palumbo; O Sezer; S V Rajkumar; B G M Durie
Journal: Leukemia Date: 2011-07-29 Impact factor: 11.528

4 in total